Research Areas
In this section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 1064 | Prop-2-ynyl-2-aminotetraline hydrochloride | Dopamine agonist | Inquire | |
| 1077 | (+)-Epibatidine dihydrochloride | Nicotinic acetylcholine receptor agonist | €155.00 | |
| 1594 | (+)-Pagoclone | GABAA-α2 and GABAA-α3 agonist | €135.00 | |
| 1073 | (+)-PD 128907 hydrochloride | D3 agonist | €110.00 | |
| 1071 | (+)-PHNO hydrochloride | D2 agonist | €110.00 | |
| 2239 | (+)-ZK 216348 | Selective nonsteroidal glucocorticoid receptor (GR) agonist | €125.00 | |
| 1078 | (-)-Epibatidine dihydrochloride | Nicotinic acetylcholine receptor agonist | €155.00 | |
| 1092 | (-)-NPPCC | 5-HT1A agonist | Inquire | |
| 1074 | (-)-PD 128907 hydrochloride | D3 agonist | €135.00 | |
| 1049 | (R)-(+)-5-methoxy-2-aminotetraline hydrochloride | Dopamine agonist | Inquire | |
| 1013 | (R)-(+)-7-Hydroxy-DPAT hydrobromide | D3 agonist | Inquire | |
| 1016 | (R)-(+)-8-Hydroxy-DPAT hydrobromide | 5-HT1A agonist | €105.00 | |
| 1026 | (R)-5-Methoxy-N-propyl-2-aminotetraline hydrochloride | Dopamine agonist | Inquire | |
| 1010 | (R)-6-Hydroxy-DPAT hydrobromide | Dopamine agonist | Inquire | |
| 1997 | (R)-6-Hydroxybuspirone hydrochloride | 5-HT1A partial agonist | €105.00 | |
| 1055 | (R)-7-Methoxy-2-aminotetraline hydrochloride | Dopamine agonist | €125.00 | |
| 1036 | (R)-PPHT hydrochloride | (R)-enantiomer of PPHT (Axon 1035); D2 agonist | Inquire | |
| 1739 | (RS)-3,5-DHPG | mGluR1 and mGluR5 agonist (rac. Axon 1740) | €80.00 | |
| 1050 | (S)-(-)-5-methoxy-2-aminotetraline hydrochloride | Dopamine agonist | €145.00 | |
| 1014 | (S)-(-)-7-Hydroxy-DPAT hydrochloride | D3 agonist | €115.00 | |
| 1017 | (S)-(-)-8-Hydroxy-DPAT hydrobromide | 5-HT1A agonist | €115.00 | |
| 1740 | (S)-3,5-DHPG | mGluR1 and mGluR5 agonist | €80.00 | |
| 1008 | (S)-5-Hydroxy-DPAT hydrobromide | D2 agonist | €145.00 | |
| 1027 | (S)-5-Methoxy-N-propyl-2-aminotetraline hydrochloride | Dopamine agonist | Inquire | |
| 1011 | (S)-6-Hydroxy-DPAT hydrobromide | Dopamine agonist | Inquire | |
| 1998 | (S)-6-Hydroxybuspirone hydrochloride | 5-HT1A partial agonist | €105.00 | |
| 1037 | (S)-PPHT hydrochloride | (S)-enantiomer of PPHT (Axon 1035); D2 agonist | Inquire | |
| 3488 | (±)-CGP-12177A | β1/β2 adrenoceptor antagonist, β3 adrenoceptor agonist | €120.00 | |
| 1076 | (±)-Epibatidine dihydrochloride | Nicotinic acetylcholine receptor agonist | €95.00 | |
| 1072 | (±)-PD 128907 hydrochloride | D3 agonist | €95.00 | |